These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3195602)

  • 1. Medullary thyroid carcinomas express chromogranin A and a novel neuroendocrine protein recognized by monoclonal antibody HISL-19.
    Deftos LJ; Woloszczuk W; Krisch I; Horvat G; Ulrich W; Neuhold N; Braun O; Reiner A; Srikanta S; Krisch K
    Am J Med; 1988 Dec; 85(6):780-4. PubMed ID: 3195602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of Chromogranin A in human neuroendocrine cell lines by immunohistology and immunoassay.
    Deftos LJ; Linnoila RI; Carney DN; Burton DW; Leong SS; O'Connor DT; Murray SS; Gazdar AF
    Cancer; 1988 Jul; 62(1):92-7. PubMed ID: 2838150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromogranin A and B and secretogranin II in medullary carcinomas of the thyroid.
    Schmid KW; Fischer-Colbrie R; Hagn C; Jasani B; Williams ED; Winkler H
    Am J Surg Pathol; 1987 Jul; 11(7):551-6. PubMed ID: 3300386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin and chromogranin A localization in medullary carcinoma of the thyroid by immunoelectron microscopy.
    Silver MM; Hearn SA; Lines LD; Troster M
    J Histochem Cytochem; 1988 Aug; 36(8):1031-6. PubMed ID: 3392392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct patterns of chromogranin A-related species can be demonstrated in endocrine cells.
    Deftos LJ; Gazdar AF; Hogue-Angeletti R; Mullen PS; Burton DW
    Bone Miner; 1990 Jun; 9(3):169-78. PubMed ID: 2163712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of FoxA1 expression in thyroid tumors.
    Nonaka D
    Hum Pathol; 2017 Jul; 65():217-224. PubMed ID: 28546130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical, biochemical and immunoelectron microscopic analysis of antigenic proteins on neuroendocrine cell tumors using monoclonal antibody HISL-19.
    Shimizu K; Namimatsu S; Kitagawa W; Akasu H; Takatsu K; Sugisaki Y; Tanaka S
    J Nippon Med Sch; 2002 Aug; 69(4):365-72. PubMed ID: 12187369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromogranin A immunoreactivity compared with argyrophilia, calcitonin immunoreactivity, and amyloid as tumour markers in the histopathological diagnosis of medullary (C-cell) thyroid carcinoma.
    Harach HR; Wilander E; Grimelius L; Bergholm U; Westermark P; Falkmer S
    Pathol Res Pract; 1992 Feb; 188(1-2):123-30. PubMed ID: 1594480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroid.
    Hanna FW; Ardill JE; Johnston CF; Cunningham RT; Curry WJ; Russell CF; Buchanan KD
    J Endocrinol; 1997 Feb; 152(2):275-81. PubMed ID: 9071985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Calcitonin Non-producing Neuroendocrine Tumor of the Thyroid Gland.
    Kasajima A; Cameselle-Teijeiro J; Loidi L; Takahashi Y; Nakashima N; Sato S; Fujishima F; Watanabe M; Nakazawa T; Naganuma H; Kondo T; Kato R; Sasano H
    Endocr Pathol; 2016 Dec; 27(4):325-331. PubMed ID: 26860935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical characterization of a novel secretory protein (defined by monoclonal antibody HISL-19) of peptide hormone producing cells which is distinct from chromogranin A, B, and C.
    Krisch K; Horvat G; Krisch I; Wengler G; Alibeik H; Neuhold N; Ulrich W; Braun O; Hochmeister M
    Lab Invest; 1988 Apr; 58(4):411-20. PubMed ID: 2833657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromogranin A as tumor marker in medullary thyroid carcinoma.
    Blind E; Schmidt-Gayk H; Sinn HP; O'Connor DT; Raue F
    Thyroid; 1992; 2(1):5-10. PubMed ID: 1356053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretogranin IV immunoreactivity in medullary thyroid carcinoma: an immunohistochemical study of 62 cases.
    Neuhold N; Ullrich R
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(2):85-9. PubMed ID: 7692664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions.
    Komminoth P; Roth J; Saremaslani P; Matias-Guiu X; Wolfe HJ; Heitz PU
    Am J Surg Pathol; 1994 Apr; 18(4):399-411. PubMed ID: 8141431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromogranin A: an additional tumor marker for postoperative recurrence and metastases of medullary thyroid carcinomas?
    Franke WG; Pinkert J; Runge R; Bredow J; Wunderlich G; Koch R
    Anticancer Res; 2000; 20(6D):5257-60. PubMed ID: 11326706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of chromogranin A and synaptophysin in medullary thyroid carcinoma.
    Tomita T
    Bosn J Basic Med Sci; 2021 Oct; 21(5):535-541. PubMed ID: 33485291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Utility of INSM1 in Medullary Thyroid Carcinoma.
    Seok JY; Kang M; De Peralta-Venturina M; Fan X
    Int J Surg Pathol; 2021 Sep; 29(6):615-626. PubMed ID: 33650906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medullary thyroid carcinoma. Immunohistochemical markers in histopathology and research].
    Schmid KW; Böcker W
    Zentralbl Pathol; 1993 Jun; 139(2):115-29. PubMed ID: 8369268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin-Negative Neuroendocrine Tumor of the Thyroid.
    Parmer M; Milan S; Torabi A
    Int J Surg Pathol; 2017 Apr; 25(2):191-194. PubMed ID: 27658647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of chromogranin A and secretogranin I (chromogranin B) in neuroendocrine cells and tumors.
    Lloyd RV; Cano M; Rosa P; Hille A; Huttner WB
    Am J Pathol; 1988 Feb; 130(2):296-304. PubMed ID: 3341449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.